While researchers all over the globe race against time to find a viable vaccine for COVID-19, Oxford University is leading the pack. They have one man to thank: Bruno Holthof, once the head of Flanders’ largest clinic (UZA in Antwerp) and currently CEO of Oxford University Hospitals. Holthof is overseeing an ambitious plan to innovate and expand the existing hospital site.
Little did he know that stopping a worldwide pandemic would become one of his responsibilities. He realized a shift in researchers, doctors, nurses and even students to develop “an entire ecosystem that is crucial for the turbocharged development of a vaccine in a hypercompetitive environment like ours,” Holthof explains.